ARTICLE | Clinical News
Sodium oxybate regulatory update
August 9, 2010 7:00 AM UTC
UCB Group (Euronext:UCB, Brussels, Belgium) disclosed in its 2Q10 financial results that it submitted an MAA to European Medicines Agency (EMA) for Xyrem sodium oxybate to treat fibromyalgia. The co...